Specific metabolic changes in DNA-treated L1210 leukemia cells.
D000818:Animals; D002247:Carbon Isotopes; D046508:Culture Techniques; D004247:DNA / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000494:pharmacology*; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology; D004926:Escherichia coli; D005467:Floxuridine / Q000494:pharmacology; D007939:Leukemia L1210 / Q000378:metabolism*; D008239:Lysine / Q000378:metabolism; D051379:Mice; D011691:Puromycin / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D013936:Thymidine / Q000378:metabolism; D013950:Thymus Gland / Q000166:cytology; D014529:Uridine / Q000378:metabolism
D002247:Carbon Isotopes; D004269:DNA, Bacterial; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D005467:Floxuridine; D003609:Dactinomycin; D011691:Puromycin; D004247:DNA; D008239:Lysine; D013936:Thymidine; D014529:Uridine